Resigratinib (KIN-3248) is a FGFR tyrosine kinase inhibitor, with antineoplastic effect.
References:
[1]. Franovic, et al. Treatment of cancer with an FGFR kinase inhibitor. World Intellectual Property Organization, WO2023107979 A1 2023-06-15.
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1 mg | ¥2,835.00 | 现货 | 1 | |
| 10mM (in 1mL DMSO) | ¥8,086.00 | 现货 | 1 |
















Resigratinib (KIN-3248) is a FGFR tyrosine kinase inhibitor, with antineoplastic effect.
References:
[1]. Franovic, et al. Treatment of cancer with an FGFR kinase inhibitor. World Intellectual Property Organization, WO2023107979 A1 2023-06-15.